Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
News|Articles|August 7, 2017
IPEC Announces 2017 Award Season Winners
Author(s)Pharmaceutical Technology Editors
The International Pharmaceutical Excipients Council (IPEC) has announced the winners of the 2017 award season.
Advertisement
The International Pharmaceutical Excipients Council (IPEC) Foundation announced the 2017 award season winners, who will be recognized for their contributions to the field of excipients during the IPEC Foundation Awards dinner on Nov. 12, 2017 in San Diego, CA. The recipients of each award are mentioned below.
Dale Eric Wurster, professor at the University of Iowa College of Pharmacy, is the recipient of the Ralph Shangraw Memorial Award. Dr. Stuart C. Porter, director and senior research fellow of Ashland Specialty Ingredients in Wilmington, DE, is the recipient of the Louis Blecher Memorial Outstanding Lifetime Achievement Award. Jie Shen, PhD, assistant professor of the departments of biomedical and pharmaceutical sciences and chemical engineering at the University of Rhode Island, is the winner of the Emerging Researcher Award.
Additionally, Dieter Lubda, PhD, director actives and formulation R&D operations at Merck KGaA-Process Solutions in Darmstadt, Germany, is the winner of the Industry Research Achievement in Excipient Technology Award. Graduate student award winners include Janki Andhariya from the University of Connecticut; Carolina del Pilar Mora Guerrero from Purdue University; Sampada Koranne from the University of Minnesota; Shreya S. Kulkarni from the University of Connecticut; and Tze Ning Hiew from the National University of Singapore.
Source:
Advertisement
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Advertisement
Advertisement